 |
12 Diseases |  |
0 Trials |
|
0 Trials |  |
24 News |  |
- ||||| Sollpura (liprotamase) / Anthera Pharma
Enrollment closed, Trial primary completion date, Head-to-Head: RESULT: Reliable, Emergent Solution Using Liprotamase Treatment (clinicaltrials.gov) - Mar 8, 2018
P3, N=140, Active, not recruiting, Sponsor: Anthera Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2018 --> Feb 2018
- | Sollpura (liprotamase) / Anthera Pharma
Enrollment closed, Trial primary completion date: SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (clinicaltrials.gov) - Jan 17, 2018
P3, N=15, Active, not recruiting, Sponsor: Anthera Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2018 --> Feb 2018 Completed --> Active, not recruiting | Trial primary completion date: Oct 2016 --> Dec 2018
- || Sollpura (liprotamase) / Anthera Pharma
Trial primary completion date: EASY: Extended Access to Sollpura Over Years (clinicaltrials.gov) - Oct 3, 2017
P4, N=70, Recruiting, Sponsor: Anthera Pharmaceuticals
Completed --> Active, not recruiting | Trial primary completion date: Oct 2016 --> Dec 2018 Trial primary completion date: Sep 2017 --> Dec 2018
- ||||||| Sollpura (liprotamase) / Anthera Pharma
Trial completion, Preclinical, Trial primary completion date, Head-to-Head: SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis (clinicaltrials.gov) - May 23, 2017
P3, N=128, Completed, Sponsor: Anthera Pharmaceuticals
Trial primary completion date: Sep 2017 --> Dec 2018 Active, not recruiting --> Completed | Trial primary completion date: Feb 2017 --> Oct 2016
- || Sollpura (liprotamase) / Anthera Pharma
Trial completion, Enrollment change, Trial primary completion date: SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (clinicaltrials.gov) - May 23, 2017
P3, N=15, Completed, Sponsor: Anthera Pharmaceuticals
Active, not recruiting --> Completed | Trial primary completion date: Feb 2017 --> Oct 2016 Recruiting --> Completed | N=46 --> 15 | Trial primary completion date: Jun 2017 --> Oct 2016
- |||||| Sollpura (liprotamase) / Anthera Pharma
Enrollment open, Head-to-Head: RESULT: Reliable, Emergent Solution Using Liprotamase Treatment (clinicaltrials.gov) - May 8, 2017
P3, N=150, Recruiting, Sponsor: Anthera Pharmaceuticals
Recruiting --> Completed | N=46 --> 15 | Trial primary completion date: Jun 2017 --> Oct 2016 Not yet recruiting --> Recruiting
- |||||||||| Sollpura (liprotamase) / Anthera Pharma
New P3 trial, Head-to-Head: RESULT: Reliable, Emergent Solution Using Liprotamase Treatment (clinicaltrials.gov) - Feb 13, 2017
P3, N=150, Not yet recruiting, Sponsor: Anthera Pharmaceuticals
- |||| Sollpura (liprotamase) / Anthera Pharma
Enrollment open: EASY: Extended Access to Sollpura Over Years (clinicaltrials.gov) - Sep 23, 2016
P4, N=70, Recruiting, Sponsor: Anthera Pharmaceuticals
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| Sollpura (liprotamase) / Anthera Pharma
Enrollment closed, Preclinical, Head-to-Head: SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis (clinicaltrials.gov) - Aug 31, 2016
P3, N=126, Active, not recruiting, Sponsor: Anthera Pharmaceuticals
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| Sollpura (liprotamase) / Anthera Pharma
New P4 trial: EASY: Extended Access to Sollpura Over Years (clinicaltrials.gov) - Jul 6, 2016
P4, N=70, Not yet recruiting, Sponsor: Anthera Pharmaceuticals
- | Sollpura (liprotamase) / Anthera Pharma
Enrollment open: SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (clinicaltrials.gov) - Jun 28, 2016
P3, N=46, Recruiting, Sponsor: Anthera Pharmaceuticals
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||| Sollpura (liprotamase) / Anthera Pharma
New P3 trial: SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis (clinicaltrials.gov) - Apr 12, 2016
P3, N=46, Not yet recruiting, Sponsor: Anthera Pharmaceuticals
- |||||| Sollpura (liprotamase) / Anthera Pharma
Enrollment open, Preclinical, Head-to-Head: SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis (clinicaltrials.gov) - Oct 3, 2015
P3, N=126, Recruiting, Sponsor: Anthera Pharmaceuticals
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| Sollpura (liprotamase) / Anthera Pharma
New P3 trial, Preclinical, Head-to-Head: SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis (clinicaltrials.gov) - Oct 31, 2014
P3, N=126, Not yet recruiting, Sponsor: Anthera Pharmaceuticals
- Sollpura (liprotamase) / Anthera Pharma
Trial initiation date: DIGEST CP: Phase III ALTU-135 CP Safety Trial (clinicaltrials.gov) - Oct 24, 2014
P3, N=39, Terminated, Sponsor: Anthera Pharmaceuticals
Not yet recruiting --> Recruiting Initiation date: Jul 2007 --> Dec 2007